Marek Schnitzer

Dr. Marek Schnitzer

Technical University of Kosice
+1
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Journal of Biotechnology
Verified
Journal Article
Closed access
ABAlena Findrik Balogová
Alena Findrik Balogová
RHRadovan Hudák
Radovan Hudák
TTTeodor Toth
Teodor Toth
MSMarek Schnitzer
Marek Schnitzer
JFJozef Feranc
Jozef Feranc
JŽJozef Živčák
Jozef Živčák

15 March 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Radovan HudákRadovan Hudák
Radovan Hudák
MSMarek Schnitzer
Marek Schnitzer
ZKZuzana Orságová Králová
Zuzana Orságová Králová
RGRadka Gorejová
Radka Gorejová
LMLukáš Mitrík
Lukáš Mitrík
JZJozef Zivcak
Jozef Zivcak
This work is devoted to the research of porous titanium alloy structures suitable for use in biomedical applications. Mechanical properties were examined on six series of samples with different structures and porosity via static compressive test to identify the type of structure suitable for elimination of the “stress shielding” effect. In addition, high porosity is desirable due to the overgrowth of bone tissue into the internal structure of the implant. The samples were made of titanium alloy Ti6Al4V by using selective laser melting (SLM) additive manufacturing. The series of samples differ from each other in pore size (200, 400, and 600 µm) and porous structure topology (cubic or trabecular). The actual weight of all samples, which plays an important role in identifying other characteristics, was determined. Compressive tests were focused on the detection of maximum stress. The highest porosity and thus the lowest weight were achieved in the samples with a trabecular structure and 600 µm pore size. All tested samples reached optimal values of maximum stress and tensile strength. The most appropriate mechanical properties were observed for samples with a 200 µm pore diameter and cubic structure.

7 December 2022 in Polymers
Verified
Journal Article
Open access
PDF file
MKMiroslav Kohan
Miroslav Kohan
SLSamuel Lancoš
Samuel Lancoš
MSMarek Schnitzer
Marek Schnitzer
JZJozef Zivcak
Jozef Zivcak
RHRadovan Hudák
Radovan Hudák
One trend in tissue engineering and regenerative medicine is the development of degradable composite polymers. The aim of this study was the comprehensive analysis of Polylactic acid (PLA)/Polyhydroxybutyrate (PHB) + Hydroxyapatite (HA)/Tricalcium phosphate (TCP) material from filament production to mechanical testing of samples with different infills and the production of an implant replacement for an intervertebral disc. Filament Maker—Composer 450 (3devo; Netherlands) was used to produce filaments. Experimental samples and the implant for the intervertebral disc were made using FDM technology using a DeltiQ2 3D printer (Trilab, Czech Republic). Mechanical testing of experimental samples was performed on an Inspekt TABLE 5 kN (Hegewald & Peschke, Nossen, Germany). Microscopic analysis, cytotoxicity test, and filament diameter analysis using descriptive statistics were also part of the focus. The results of the analysis of the diameter of the filament show that the filament meets the prescribed standard. The cytotoxicity test for PLA/PHB + HA/TCP material showed no toxicity. Microscopic analysis showed an even distribution of the ceramic component in the composite polymer. Mechanical testing showed a reduction in mechanical properties with 75% and 50% of the filling of experimental samples. All experimental samples subjected to mechanical testing showed higher tensile and compressive strength values compared to the values of the mechanical properties of vertebral trabecular bones, as reported in the literature. It can therefore be concluded that the material under investigation, PLA/PHB + HA/TCP appears to be a suitable candidate for hard tissue replacement.

12 December 2022 in Polymers
Verified
Journal Article
Open access
PDF file
ABAlena Findrik Balogová
Alena Findrik Balogová
MTMarianna Trebuňová
Marianna Trebuňová
DBDarina Bačenková
Darina Bačenková
MKMiroslav Kohan
Miroslav Kohan
Radovan HudákRadovan Hudák
Radovan Hudák
JZJozef Zivcak
Jozef Zivcak
The present study deals with preparing a polymer-based material with incorporated ceramics and monitoring changes in properties after in vitro natural degradation. The developed material is a mixture of polymers of polylactic acid and polyhydroxybutyrate in a ratio of 85:15. Ceramic was incorporated into the prepared material, namely 10% hydroxyapatite and 10% tricalcium phosphate of the total volume. The material was processed into a filament form, and types of solid and porous samples were prepared using additive technology. These samples were immersed in three different solutions: physiological solution, phosphate-buffered saline, and Hanks’ solution. Under constant laboratory conditions, changes in solution pH, material absorption, weight loss, changes in mechanical properties, and surface morphology were monitored for 170 days. The average value of the absorption of the solid sample was 7.07%, and the absorption of the porous samples was recorded at 8.33%, which means a difference of 1.26%. The least change in pH from the reference value of 7.4 was noted with the phosphate-buffered saline solution. Computed tomography was used to determine the cross-section of the samples. The obtained data were used to calculate the mechanical properties of materials after degradation. The elasticity modulus for both the full and porous samples degraded in Hanks’ solution (524.53 ± 13.4 MPa) has the smallest deviation from the non-degraded reference sample (536.21 ± 22.69 MPa).


7 February 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
DBDarina Bačenková
Darina Bačenková
MTMarianna Trebuňová
Marianna Trebuňová
TŠTatiana Špakovská
Tatiana Špakovská
MSMarek Schnitzer
Marek Schnitzer
LBLucia Bednarčíková
Lucia Bednarčíková
JZJozef Zivcak
Jozef Zivcak
The global pandemic known as coronavirus disease 2019 (COVID-19) was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This review article presents the taxonomy of SARS-CoV-2 coronaviruses, which have been classified as the seventh known human pathogenic coronavirus. The etiology of COVID-19 is also briefly discussed. Selected characteristics of SARS-CoV-2, SARS-CoV, and HCoV-NL63 are compared in the article. The angiotensin converting enzyme-2 (ACE-2) has been identified as the receptor for the SARS-CoV-2 viral entry. ACE2 is well-known as a counter-regulator of the renin-angiotensin system (RAAS) and plays a key role in the cardiovascular system. In the therapy of patients with COVID-19, there has been a concern about the use of RAAS inhibitors. As a result, it is hypothesized that ACE inhibitors do not directly affect ACE2 activity in clinical use. Coronaviruses are zoonotic RNA viruses. Identification of the primary causative agent of the SARS-CoV-2 is essential. Sequencing showed that the genome of the Bat CoVRaTG13 virus found in bats matches the genome of up to (96.2%) of SARS-CoV-2 virus. Sufficient knowledge of the molecular and biological mechanisms along with reliable information related to SARS-CoV-2 gives hope for a quick solution to epidemiological questions and therapeutic processes.